Valuation: Adocia

Market Cap 70.08M 80.2M 65.87M 60.11M 113M 7.67B 113M 791M 305M 3.92B 301M 295M 12.62B P/E 2026 *
-654x
P/E 2027 * 5.18x
Enterprise Value 40.24M 46.05M 37.82M 34.51M 64.78M 4.4B 64.79M 454M 175M 2.25B 173M 169M 7.25B EV / Sales 2026 *
16x
EV / Sales 2027 * 2.83x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.78%
1 week-1.47%
Current month-9.48%
1 month-11.08%
3 months-11.95%
6 months-31.76%
Current year-46.12%
1 week 3.52
Extreme 3.52
3.79
1 month 3.47
Extreme 3.474
4.17
Current year 3.47
Extreme 3.474
7.45
1 year 3.47
Extreme 3.474
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 57 -
Director/Board Member 61 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/25 Buy

Founder

109,170 0.6972%
4/6/24 Buy

Founder

15,576 0.1105%
4/6/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%-1.47%-56.92%-54.25% 80.38M
-0.07%+5.66%+54.34%+113.69% 74.33B
-1.45%-0.40%+35.52%+79.18% 62.26B
-0.66%+7.14%+39.36%+29.20% 27.72B
-0.92%+0.13%-17.21%+358.81% 26.42B
+2.73%+4.15%+2.01%-3.77% 24.62B
+0.84%+6.00%+25.53%-9.89% 20.72B
+0.87%-2.52%+151.81%+328.17% 15.01B
+1.88%+2.73%+47.69%+172.14% 14.18B
+0.80%-1.87%-10.60%+813.10% 13.48B
Average +0.50%+0.77%+27.15%+182.64% 27.88B
Weighted average by Cap. +0.00%+2.10%+36.84%+149.55%

Financials

2026 *2027 *
Net sales 2.52M 2.89M 2.37M 2.16M 4.06M 276M 4.06M 28.44M 10.98M 141M 10.84M 10.6M 454M 35.4M 40.51M 33.27M 30.36M 56.98M 3.87B 56.99M 399M 154M 1.98B 152M 149M 6.38B
Net income -4.32M -4.94M -4.06M -3.7M -6.95M -472M -6.95M -48.7M -18.79M -241M -18.55M -18.15M -777M -44.33M -50.72M -41.66M -38.02M -71.35M -4.85B -71.37M -500M -193M -2.48B -190M -186M -7.98B
Net Debt -29.84M -34.15M -28.05M -25.6M -48.04M -3.26B -48.05M -337M -130M -1.67B -128M -125M -5.37B 30.18M 34.53M 28.36M 25.88M 48.58M 3.3B 48.58M 340M 131M 1.69B 130M 127M 5.43B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
26-09-22 3.610 +0.78% 62,153
26-09-21 €3.582 -1.86% 40,938
26-09-18 €3.650 -0.49% 42,096
26-09-17 €3.668 +1.78% 46,136
26-09-16 €3.604 -1.64% 67,707
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.582EUR
Average target price
9.700EUR
Spread / Average Target
+170.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!